Comparison of the incidence of smell and taste disorders between influenza and COVID-19

Claudia I Cabrera,Kayla Hicks,Kenneth Rodriguez,John A Gerka Stuyt,Grace A McComsey,Brian D'Anza,Claudia I. Cabrera,John A. Gerka Stuyt,Grace A. McComsey
DOI: https://doi.org/10.1016/j.amjoto.2023.104176
IF: 2.873
2024-05-01
American Journal of Otolaryngology
Abstract:OBJECTIVE: Smell and taste disorders among patients with COVID-19 has become increasingly reported in the literature, however the prevalence varies. Post-infectious respiratory dysfunction has also been linked to influenza. In this study, we aimed to compare the rates of smell and taste disorders between COVID-19 and Influenza in unvaccinated patients.STUDY DESIGN: Retrospective cohort study.SETTING: TriNetX research network.METHODS: Two queries were made on 7/1/2023 to include Influenza without a diagnosis of COVID-19 and a COVID-19 without a diagnosis of Influenza. The queries included patients from January 1 to December 31, 2022 from 102 Healthcare Organizations. The resultant population of patients with ICD-10 codes for COVID-19 and Influenza were matched using demographic characteristics to evaluate the risk of smell disorders.RESULTS: The overall 3-month incidence of smell and taste disorders was 0.73 % in the COVID-19 population and 0.1 % in the influenza population. The 3-month matched risk ratios were 11.1 [95 % CI (8.8,13.8)]; p < 0.001) times higher for disorders of the smell and taste secondary to COVID-19 compared to influenza.CONCLUSIONS: Disorders of the smell and taste are more common among patients with COVID-19 compared to patients with Influenza. Beyond smell loss, patients experience additional nasal and sinus-related rhinological symptoms, pointing to COVID-19's and influenza's wider impact on overall rhinological health. We believe that due to the transient nature of these disorders, they might go underreported.
otorhinolaryngology
What problem does this paper attempt to address?